Mechanisms of acid resistance due to the urease system of Helicobacter pylori.
OBJECTIVE
Helicobacter pylori, a neutralophile, uses acid neutralization by urease to combat gastric acidity, allowing gastric colonization. Both acute and chronic acid resistance mechanisms are present. Acute mechanisms of acid adaptation could be due to surface urease, increased inner-membrane urea permeability via UreI, or both. Slower mechanisms may involve increased nickel insertion into apoenzyme, posttranscriptional regulation, or increased enzyme synthesis. The aim of this study was to further define regulation of urease under acidic conditions.


METHODS
Surface-bound urease was analyzed by measurement of free and bound urease after centrifugation through a step gradient and by quantitative urease immunostaining of intact and fixed bacteria. Changes in urease synthesis or assembly were determined by incubation of the organisms at pH 5.5 or 7.0 in the absence and presence of chloramphenicol, urea, or nickel chelator and in ureI-positive and -negative organisms.


RESULTS
The amount of surface urease was below detection limits with either centrifugation washing or immunostaining. Total bacterial urease activity was increased 3-5-fold by incubation at pH 5.5 in the presence of chloramphenicol but not in nickel-free medium or in ureI knockout organisms. There was also a 3-fold increase in survival of acid shock in acid-adapted organisms.


CONCLUSIONS
Surface-bound urease is too low to contribute to acid resistance. Acidic medium pH induces UreI-dependent nickel incorporation into apoenzyme. This augmentation of urease activity increases survival in acid and is part of the gastric colonization strategy of the organism.
Scott
David R
DR
Department of Physiology, University of California Los Angeles, Los Angeles, California 90073, USA.
Marcus
Elizabeth A
EA
Weeks
David L
DL
Sachs
George
G
D000143:Acids / Q000494:pharmacology*; D015153:Blotting, Western; D002462:Cell Membrane / Q000201:enzymology; D004352:Drug Resistance, Microbial; D004789:Enzyme Activation; D016480:Helicobacter pylori / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D006863:Hydrogen-Ion Concentration; D014018:Tissue Distribution; D014510:Urease / Q000378:metabolism*
D000143:Acids; D014510:Urease